We would like to share some of the latest developments in the industry and provide an outlook of some of our key activities. If you would like to receive this update straight to your inbox, please feel free to sign up to our monthly newsletter.

Industry News

Advantages of Biomanufacturing in Small-Scale Production Facilities

In a study published in the Journal of Pharmaceutical Sciences the authors discuss the advantages of decentralized manufacturing in small-scale production facilities:

  • “Right-sizing” manufacturing of low volume products to reduce environmental impact and enhancing speed of product to patients
  • Deployment of agile technologies can be valuable in emergency situations for bringing new treatments to market, or for swift response to increasing volume demands

News at Just - Evotec Biologics

Grand Opening of J.POD® Toulouse, France (EU)

Just Newsletter News Image JPOD Toulouse EU

We are super excited about the upcoming Grand Opening of our new biomanufacturing facility in Toulouse, France! We will celebrate with local politicians and partners incl. Sandoz, with whom we recently expanded our development and manufacturing partnership.

Continuous Biomanufacturing arrives in Europe

Just Newsletter News Image EBR Article

Learn more about our new biomanufacturing facility in the recent interview with European Biopharmaceutical Review (EBR). Nick Hutchinson, Head of Market Development, explains the benefits of our Continuous Manufacturing platform and what it means for the industry. J.POD Toulouse, France (EU), is the first of its kind in Europe.

Case Study: OncoResponse Selected Just - Evotec Biologics for Phase I Clinical Manufacturing

Just Newsletter News Image Onco Response Cast Study

Learn how OncoResponse partnered with us to develop a Continuous Manufacturing process that would supply their Phase I clinical trials.

Upcoming Conferences

We are looking forward to meeting you there!

Reach out to us at info@evotec.com to set up a meeting.

Scientific Topics:

Resource Types: